-
Quinolone–Coumarin Hybrids Against Toxoplasma gondii
2026-09-14
A 2024 Acta Parasitologica study evaluated 12 quinolone–coumarin hybrids derived from fluoroquinolones and novobiocin against Toxoplasma gondii in vitro. QC1, QC3, QC6, and novobiocin showed favorable antiparasitic selectivity, reducing infection-related phenotypes without a comparable loss of healthy-cell viability and providing leads for further anti-Toxoplasma research.
-
Prednisone Assays: From Mechanism to Method
2026-09-14
Prednisone is a synthetic corticosteroid with a distinctive lymphocyte-centered assay profile. This guide connects G1 arrest, IL-2 signaling, apoptosis, solvent control, and insights from 2026 LC–MS/MS digestion research to improve experimental design without conflating botanical and corticosteroid evidence.
-
Trichostatin A (TSA) for Mechanistic Cancer Assays
2026-09-13
Trichostatin A (TSA) turns HDAC inhibition into a practical tool for linking histone acetylation with proliferation, differentiation, and centrosome biology. This guide combines product-specific handling with a reference-informed workflow for cancer and cell-cycle assays, while clearly separating broad epigenetic perturbation from SIRT1-specific conclusions.
-
Carboxylesterase Confounds Mitochondrial H₂O₂ Assays
2026-09-12
Miwa et al. showed that carboxylesterases can convert Amplex Red to resorufin without hydrogen peroxide, horseradish peroxidase, or oxygen, creating a major interpretive risk in mitochondrial H₂O₂ release assays. Their findings support matrix-specific controls, esterase inhibition experiments, and orthogonal validation before fluorescent signals are assigned to mitochondrial ROS production.
-
PLGA Nano-Adjuvant Enhances Mucosal Immunity in Chicks
2026-09-12
A 2026 Poultry Science study developed PEI-LSP-RA-PLGA, a PLGA-based, double-layer nanoparticle adjuvant designed to combine sustained release with intestinal immune targeting. In chicks receiving an inactivated H9N2 vaccine, the formulation enhanced serum IgG, intestinal IgA, immune-organ responses, and signaling associated with mucosal immunity, although protection against live-virus challenge was not established.
-
Tioconazole Workflows for Antifungal Research
2026-09-11
Build reproducible fungal growth, viability, and ergosterol-pathway experiments with Tioconazole, while controlling solvent, dosing, and storage variables. A cross-domain perspective from recent AML research adds a useful framework for separating direct antifungal effects from energy-stress and assay-context effects.
-
Chloroquine for Autophagy and Cementoblast Assays
2026-09-11
A workflow-focused guide to using Chloroquine (BA1002) to interrogate autophagy, compression responses, and cementoblast mineralization. It connects lysosomal inhibition with periostin/β-catenin biology while providing practical dosing, controls, and troubleshooting guidance for reproducible cell assays.
-
TPA as a Signaling Control in Macrophage Assays
2026-09-10
12-O-tetradecanoyl phorbol-13-acetate (TPA) is more than an ERK activator: it can serve as a mechanistic control for separating PKC/ERK signaling from LPS-driven macrophage responses. This guide integrates TPA assay design with recent findings on endogenous melatonin, IRF3, and macrophage polarization.
-
MRSA Research: Resistance, Epidemiology, and Clinical Impact
2026-09-10
Turner and colleagues provide an integrative review of how MRSA emerged, diversified, spread across health-care and community settings, and complicated treatment. Its central value is the connection of mecA-mediated resistance and clonal evolution with surveillance, transmission biology, clinical disease, and practical management decisions.
-
EPZ5676: DOT1L Inhibitor Workflow Guide
2026-09-09
Build reproducible DOT1L inhibition experiments around EPZ5676, from SAM-pocket biochemistry and H3K79 methylation inhibition to MLL-rearranged leukemia models. The guide separates validated product performance from practical starting conditions and explains how immune-signature findings from melanoma research can inform, but not replace, leukemia assay design.
-
WM-8014 for Reliable KAT6A Assays
2026-09-09
Learn how WM-8014, SKU A8779, supports interpretable cell-cycle, senescence, and epigenetic experiments without confusing growth arrest with nonspecific cytotoxicity. This scenario-based guide covers assay design, solution handling, data interpretation, and practical product-selection criteria.
-
Sulfo-Cy5 Carboxylic Acid for Multiplexed Tracing
2026-09-08
Sulfo-Cy5 carboxylic acid combines aqueous compatibility with far-red optical performance for fluorescence imaging and quantitative assay design. This article explains how to use its physicochemical properties to interpret nanoparticle trafficking and mucosal-immunity experiments without overstating what the reference study demonstrates.
-
TET2 Metabolite Binding: A Practical Protocol
2026-09-07
The 2025 STAR Protocols study establishes an orthogonal workflow that combines purified human TET2 catalytic-domain assays, flow cytometry, and saturation transfer difference NMR to distinguish metabolite binding from functional regulation. Its practical value lies in enabling systematic identification of TET2 activators and inhibitors while connecting metabolic changes with epigenetic control.
-
WM-8014 and the Logic of KAT6A-Driven Senescence
2026-09-07
WM-8014 offers a mechanistically defined way to test how KAT6A/B acetyltransferase activity links chromatin regulation to cell-cycle arrest, oncogene-induced senescence, and tumor overproliferation. This perspective connects its biochemical profile with RESTRICT-seq findings and outlines a translational workflow that separates target engagement, durable senescence, and general cytotoxicity.
-
10 mM dNTP Mixture: Reliable DNA Workflows
2026-09-05
This scenario-based guide explains how SKU K1041 supports consistent PCR, qPCR, sequencing, and DNA-synthesis workflows that accompany viability, proliferation, and cytotoxicity studies. It also clarifies what an equimolar dNTP mixture can—and cannot—solve in cell-based assays, with practical storage and selection guidance.